CTRI/2019/11/021934尚未招募未知
Comparative evaluation of Mifepristone 10 mg vs 25 mg in the management of symptomatic uterine fibroid- A Randomized controlled trial
Kavita Agarwal0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients 18-50 years with symptomatic fibroid
- •Fibroid less than 15 cm
- •Patients willing to sign informed consent and to undergo ultrasonography at 3 months
- •Patient willing to come for follow up at 3 months and 6 months
排除标准
- •Fibroid more than 15 cm
- •Fibroid with severe anemia needing blood transfusion
- •Fibroid with pressure symptoms
- •Fibroid wanting immediate surgery
- •Fibroid with pregnancy
- •Patient not willing to come for follow up
研究者
相似试验
尚未招募
Unknown
Trial of induction of labour by oral drug in late intrauterine fetal deathCTRI/2023/06/053692none
已完成
不适用
Study comparing two methods of abortion in second trimester using misoprostol or ethacridine lactate after priming with mifepristoneCTRI/2018/01/011157Project in the Department of Obstetrics and Gynecology120
尚未招募
2 期
A clinical trial comparing the safety and efficacy of mifepristone and misoprostol either alone or when used with an intracervical Foleys catheter in women desiring second-trimester medical abortionsCTRI/2024/06/069578Dr Lakshyaa Chawla
已完成
2 期
Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of EndometriosisEndometriosisNCT02271958Mediterranea Medica S. L.360
已完成
不适用
Comparison of two mifepristone doses and two misoprostol intervals for early pregnancy terminatioInduced abortionAbortionPregnancy and ChildbirthISRCTN24130607DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction2,181